Dermatology · Philadelphia, PA
NPI
1689817181
Since 2009
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3400 Civic Center Blvd., 1-330s Perelman Center
Philadelphia, PA, 19104
Phone (215) 662-2737
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
709 services
Medicare patients, 2024
185
Average age 72
Drug cost, 2024
$594K
807 prescriptions
Company payments, 2023
$30.54
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lisa K Pappas-Taffer was code 99214 (office e&m - established), 131 times for 89 patients. In total Lisa K Pappas-Taffer billed 709 services in 23 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 131 | 89 | $68.92 | $9,028 |
| 99214 Office E&M - Established | Facility | 92 | 61 | $67.92 | $6,249 |
| 17003 Destruction Skin Lesion | Office | 58 | 17 | $1.61 | $93.47 |
| 99215 Office E&M - Established | Office | 42 | 21 | $96.18 | $4,040 |
| 11102 Skin Biopsy | Office | 40 | 31 | $22.15 | $886 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 37 | 25 | $12.56 | $465 |
| 99215 Office E&M - Established | Facility | 32 | 19 | $109.31 | $3,498 |
| 17000 Destruction Skin Lesion | Office | 31 | 26 | $37.25 | $1,155 |
| 17110 Destruction Skin Lesion | Office | 26 | 22 | $52.02 | $1,352 |
| 99213 Office E&M - Established | Office | 22 | 17 | $38.68 | $851 |
| 99213 Office E&M - Established | Facility | 20 | 16 | $50.74 | $1,015 |
| 11103 Skin Biopsy | Office | 19 | 12 | $17.75 | $337 |
| 17000 Destruction Skin Lesion | Facility | 17 | 12 | $38.57 | $656 |
| 11102 Skin Biopsy | Facility | 14 | 12 | $24.33 | $341 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 14 | 12 | $13.31 | $186 |
By year: 2022 $32K for 553 services; 2023 $35K for 626 services; 2024 $34K for 709 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lisa K Pappas-Taffer prescribed most often to Medicare patients was Clobetasol Propionate, with 84 prescriptions and refills. In total Lisa K Pappas-Taffer wrote 807 Medicare prescriptions that cost $594K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 84 | 117 | 56 | $4,031 |
| Mycophenolate Mofetil Generic | 72 | 155 | 20 | $46K |
| Finasteride Generic | 57 | 169 | 17 | $537 |
| Tacrolimus Generic | 56 | 71 | 36 | $7,481 |
| Hydroxychloroquine Sulfate Generic | 52 | 149 | 16 | $2,879 |
| Minoxidil Generic | 46 | 136 | 14 | $401 |
| Ketoconazole Generic | 29 | 31 | 13 | $587 |
| Dutasteride Generic | 27 | 61 | Under 11 | $540 |
| Dupixent Syringe Dupilumab | 22 | 22 | Under 11 | $81K |
| Otezla Apremilast | 20 | 20 | Under 11 | $96K |
| Triamcinolone Acetonide Generic | 20 | 30 | 18 | $313 |
| Methotrexate Methotrexate Sodium | 17 | 46 | Under 11 | $613 |
| Pimecrolimus Generic | 17 | 18 | Under 11 | $6,579 |
| Dexamethasone Generic | 17 | 24 | Under 11 | $1,278 |
| Fluconazole Generic | 16 | 29 | Under 11 | $285 |
Brand drugs: 97 claims; generic drugs: 710 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Lisa K Pappas-Taffer $30.54 ($30.54 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $30.54.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 2 | $30.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.